Monday, December 9, 2019

Pharma Reviews: How equity investors should play the falling GDP scenario

“Due to several structural issues faced by the Indian economy, growth rate is ... The entire pharma industry can be treated as a defensive bet now because their ... Domestic woes will not affect pharmaceutical companies like Cipla.
Read more: How equity investors should play the falling GDP scenario